Back
Ultragenyx Pharmaceutical Stock Price Chart
The little-known AI stock you need to read about now...
Get the name - FREE.
Sell
38
RARE
Ultragenyx Pharmaceutical
Last Price:
44.05
Seasonality Move:
10.8%
7 Day Trial
ALL ACCESS PASS
$
7
9,530x the last time this happened
Here's what our expert says you should buy before April 14.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight buying pressure.
Ultragenyx Pharmaceutical Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 43.87 | Buy |
| 20-day SMA: | 46.21 | Sell |
| 50-day SMA: | 47.79 | Sell |
| 200-day SMA: | 42.13 | Buy |
| 8-day EMA: | 44.35 | Sell |
| 20-day EMA: | 45.49 | Sell |
| 50-day EMA: | 46.38 | Sell |
| 200-day EMA: | 44.57 | Sell |
Ultragenyx Pharmaceutical Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.09 | Sell |
| Relative Strength Index (14 RSI): | 43.92 | Sell |
| Chaikin Money Flow: | 101540 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (43.49 - 48.87) | Sell |
| Bollinger Bands (100): | (43.62 - 49.46) | Sell |
Ultragenyx Pharmaceutical Technical Analysis
| Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Ultragenyx Pharmaceutical Stock
Is Ultragenyx Pharmaceutical Stock a Buy?
- Ultragenyx Pharmaceutical share price is 44.24 while RARE 8-day simple moving average is 43.87, which is a Buy signal.
- The stock price of RARE is 44.24 while Ultragenyx Pharmaceutical 20-day SMA is 46.21, which makes it a Sell.
- Ultragenyx Pharmaceutical 50-day simple moving average is 47.79 while RARE share price is 44.24, making it a Sell technically.
- RARE stock price is 44.24 and Ultragenyx Pharmaceutical 200-day simple moving average is 42.13, creating a Buy signal.
RARE Technical Analysis vs Fundamental Analysis
Sell
38
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy or a Sell?
-
Ultragenyx Pharmaceutical stock is rated a Sell
The current Ultragenyx Pharmaceutical [RARE] share price is $44.24. The Score for RARE is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
Ultragenyx Pharmaceutical Stock Info
Market Cap:
3.64B
Price in USD:
44.24
Share Volume:
450.42K
Ultragenyx Pharmaceutical 52-Week Range
52-Week High:
54.98
52-Week Low:
31.52
Sell
38
Ultragenyx Pharmaceutical (RARE)
is a Sell
Ultragenyx Pharmaceutical Share Price Forecast
-
What is the Ultragenyx Pharmaceutical stock price today?
The Ultragenyx Pharmaceutical stock price is 44.24 USD today. -
Will RARE stock go up or go down?
Ultragenyx Pharmaceutical> share price is forecast to RISE/FALL based on technical indicators -
Is Ultragenyx Pharmaceutical overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Ultragenyx Pharmaceutical is overvalued.
Is Ultragenyx Pharmaceutical Stock a Buy?
- Ultragenyx Pharmaceutical share price is 44.24 while RARE 8-day exponential moving average is 44.35, which is a Sell signal.
- The stock price of RARE is 44.24 while Ultragenyx Pharmaceutical 20-day EMA is 45.49, which makes it a Sell.
- Ultragenyx Pharmaceutical 50-day exponential moving average is 46.38 while RARE share price is 44.24, making it a Sell technically.
- RARE stock price is 44.24 and Ultragenyx Pharmaceutical 200-day simple moving average is 44.57, creating a Sell signal.
Fundamental Analysis of Ultragenyx Pharmaceutical
Is Ultragenyx Pharmaceutical a good investment?
- Analysts estimate an earnings increase this quarter of $0.39 per share, an increase next quarter of $0.02 per share, an increase this year of $1.08 per share, and an increase next year of $0.95 per share.
Technical Analysis of Ultragenyx Pharmaceutical
Should I short Ultragenyx Pharmaceutical stock?
- RARE Moving Average Covergence Divergence (MACD) indicator is -1.09, suggesting Ultragenyx Pharmaceutical is a Sell
- Ultragenyx Pharmaceutical Relative Strength Index (RSI) is 43.92, which suggest Ultragenyx Pharmaceutical is oversold
- The Bollinger Bands (25) for Ultragenyx Pharmaceutical is (43.49 - 48.87), which suggest Ultragenyx Pharmaceutical is a Sell
- The Bollinger Bands (100) for Ultragenyx Pharmaceutical is (43.62 - 49.46), which suggest Ultragenyx Pharmaceutical is a Sell
* Ultragenyx Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.